A Adanali New member 1 Ara 2022 #1 We must temper celebrations over the new Alzheimer’s drug Biogen and Eisai caused a stir in September when they announced positive results in a late-stage trial for an Alzheimer’s drug, lecanemab
We must temper celebrations over the new Alzheimer’s drug Biogen and Eisai caused a stir in September when they announced positive results in a late-stage trial for an Alzheimer’s drug, lecanemab
